Just a bad biotech tape lately...no issues here as fundamentals have never been better with strong institutional support. This will be a snap back to test $30 and slow grind to $40 but will happen in next couple months imo. The only real positive biotech movers on my tape today were TSRO and INSM. Both also have solid catalysts in near term with lots upside....
I have been long just recently- look for continued runup as shorts trapped here (only 18mil float) with 2 mil shrs short. Big squeeze coming as we and a few others are adding...:) dangerous game here for shorts as institutions will be adding as fundamentals are good here with their existing positive phase 3 data and the global licensing deal for portfolio of antibodies for cancer immunotherapies just puts this stock much too cheap. Shorts will be scrambling over $50 soon. Check out INSM also been a long holder of this one - moving up on heavy volume today ahead of clinical trials for NTM lung infections in next 2 wks. Think data will be positive as they have history of positive data with the product even in phase 3 trials for CF patients....look for big move up in INSM also....:)
Given the drug platform and upcoming catalysts I like the potential for NTM and CF. Stay the course and understand the drug and previous trial results. Don't pay too much attention to the noise and you will see how attractive this investment is based on risk/reward. Lets see who is correct by next month....:) GL to all even the shorts...lol
Agreed here. There has been no news just based on analyst opinion basically saying that he was somewhat wrong before...Think there are other motives here as Wedbush was one of the few firms left out in the last fundraising round...:) Perhaps some sour grapes for not getting any banking fees? Also their pt doesn't make sense as they didn't come out and say that they thought data would be negative for NTM. There is limited options for patients suffering from NTM so with positive data from upcoming trial I believe FDA will work with the company to make this available to the public quickly...Today is a buying opportunity imo. GL to all
This will be fun as there are lots more upside from these levels. Look at valuation, this could easily be over 400 mil mkt cap. Very attractive assets also for many suitors....:)
Overall mkt has been weak but select biotech will still outperform this year as pharma races to expand their current weak drug pipeline and will see more deals. FDA has been very active in allowing novel drugs that show efficacy for indications with little treatment options. INSM continues to be my top holding- we have been through many cycles with this company and I believe that we are about to enter more commercialization phase with upcoming positive surprises even non-Arikace...:) My feeling is that many will look back and wonder why they didn't invest more $$$ here as Lewis will soon turn this company into multi-Billion $ biopharma. Look back at my previous posts I have been very transparent in my views and outlook. Stay the course as our investment here will really accelerate higher imho...Good luck to all and invest based on your analysis and diligence these opportunities will not always present themselves....:)
We have initiated a position recently in last week...Think easy double from these levels, very high likelihood of approval and adoption. My friends are scaling in and will be adding. Def oversold - i knew it was a buy when my friends who were short kept asking me what i thought about it down here...We have had a few nice pickups in last 18 months- INSM, VPHM, HALO, ONXX, PACB, ALNY, ACAD, KERX....This will be another good one imo....:)
We have seen this over and over with the clown AF- no reason to complain he is helping out his buddies who are short. I just buy and celebrate new highs in a week....:) We are buyers at these levels...